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Abstract
The TransfersomeH is a lipid vesicle that contains membrane softeners, such as Tween 80, to make it ultra-deformable. This
feature makes the TransfersomeH an efficient carrier for delivery of therapeutic drugs across the skin barrier. It was reported
that TDT 067 (a topical formulation of 15 mg/ml terbinafine in TransfersomeH vesicles) has a much more potent antifungal
activity in vitro compared with conventional terbinafine, which is a water-insoluble fungicide. Here we use ultra-structural
studies and live imaging in a model fungus to describe the underlying mode of action. We show that terbinafine causes
local collapse of the fungal endoplasmic reticulum, which was more efficient when terbinafine was delivered in
TransfersomeH vesicles (TFVs). When applied in liquid culture, fluorescently labeled TFVs rapidly entered the fungal cells
(T1/2,2 min). Entry was F-actin- and ATP-independent, indicating that it is a passive process. Ultra-structural studies
showed that passage through the cell wall involves significant deformation of the vesicles, and depends on a high
concentration of the surfactant Tween 80 in their membrane. Surprisingly, the TFVs collapsed into lipid droplets after
entry into the cell and the terbinafine was released from their interior. With time, the lipid bodies were metabolized in an
ATP-dependent fashion, suggesting that cytosolic lipases attack and degrade intruding TFVs. Indeed, the specific
monoacylglycerol lipase inhibitor URB602 prevented TransfersomeH degradation and neutralized the cytotoxic effect of
TransfersomeH-delivered terbinafine. These data suggest that (a) Transfersomes deliver the lipophilic fungicide Terbinafine
to the fungal cell wall, (b) the membrane softener Tween 80 allows the passage of the Transfersomes into the fungal cell,
and (c) fungal lipases digest the invading TransfersomeH vesicles thereby releasing their cytotoxic content. As this mode
of action of Transfersomes is independent of the drug cargo, these results demonstrate the potential of Transfersomes in
the treatment of all fungal diseases.
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Introduction
Targeted delivery of therapeutic drugs has the potential to
reduce the effective drug dosage and avoid toxic side-effects, while
maintaining the desired response [1]. One way to achieve this is
through the use of lipid carrier vesicles [2,3] that, when locally
applied, penetrate the skin and allow targeted delivery of the
enclosed drug. In recent years, numerous studies have reported the
successful use of an ultra-deformable lipid vesicle, the Transfer-
someH [4–9]; overview in [10,11]. The membrane of the
TransfersomeH consists of a lipid (e.g. phosphatidylcholine) and
a membrane-softening agent (e.g. Tween 80). Due to its
characteristic membrane composition, the TransfersomeH can
extremely deform, enabling spontaneous and efficient penetration
of human skin by passing through intercellular spaces that are 5–
10-times smaller than the size of the vesicle [1,6]. This technology
can efficiently deliver therapeutically active drugs across the skin
barrier to subcutaneous tissue, and comparative studies have
shown that TransfersomeH-enclosed therapeutic drugs are more
efficient than when applied in a conventional way (e.g. hydrogel
application [4,12]). This allows a more targeted and measured
therapeutic approach that is based on a lower and, therefore, more
tolerable drug dosage.
Onychomycosis is a common fungal disease of the nail, infecting
up to 20% of the population over age 40 [13]. It is most frequently
caused by the dermatophytes Trichophyton rubrum and T. menta-
grophytes [14]. The treatment of onychomycosis has improved
considerably since the introduction of the oral antifungal agents
terbinafine and itraconazole [15]. However, drug–drug interac-
tions and hepatotoxicity have been reported among patients
treated with these oral antifungals [16,17], highlighting the need
for effective topical therapies which would avoid systemic exposure
to the antifungal agent. In vitro experiments have demonstrated
that TDT 067 (a topical formulation of 1.5% terbinafine in
TransfersomeH) has potent inhibitory activity against dermato-
phytes [18]. These experiments also demonstrated that TDT 067
has enhanced antifungal activity compared with ‘‘naked’’ terbin-
afine [18]. Following treatment with TDT 067, dermatophyte
hyphae isolated from clinical samples showed extensive ultra-
structural changes, indicative of death of the pathogen [19]. In
both clinical samples and in T. rubrum hyphae exposed to TDT
067 in vitro, the fungal cells accumulated characteristic structures
that appear solid and grayish in electron microscopy studies and
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of these structures, nor the precise mechanisms underlying the
increased antifungal activity of TDT 067 is known.
This paper addresses the mode of action of TFVs in antifungal
delivery. Terbinafine is known to inhibit a key fungal enzyme in
sterol biosynthesis [21,22]. As sterols determine membrane
properties and organization of membrane sub-domains [23], the
paper investigates the effects of terbinafine-loaded TFVs and
conventional terbinafine on organelle organization and dynamics
in the model fungus Ustilago maydis. It is shown here that entry of
terbinafine-loaded TFVs into the fungal cell depends on the
amount of the surfactant in their membrane and that they are
more cytotoxic than the naked fungicide. This is due to an
enzymatic and ATP-dependent digestion of the passively invading
TFVs, which releases their content and increases the fungicide
concentration locally. This degradation, as well as the cytotoxicity
of terbinafine-loaded TFVs, can be neutralized by the addition of
lipase inhibitors. This suggests that TFVs act as ‘‘Trojan Horses’’
that get degraded by fungal lipases, thereby releasing the
fungicide. As this mode of action is not depending on the loaded
drug, Transfersome technology promises an efficient way of
treating fungal diseases in general.
Results
Delivery in TransfersomeH vesicles enhances the
antifungal activity of terbinafine
To test the efficiency of terbinafine-containing TFVs, a strain of
U. maydis, in which organelles were stably labeled with specific
fluorescent marker proteins, was incubated with various concen-
trations of terbinafine to enable the observation of the dynamic
behavior and the organization of nuclei, peroxisomes, vacuoles,
mitochondria, early endosomes, and the endoplasmic reticulum
(for a description of fungal strains, see Methods and Table 1).
In order to recognize specific effects of terbinafine, we focused
on changes in organelle appearance after 30 min of exposure.
Under these conditions, terbinafine treatment had no obvious
effect on the organization of most organelles (Fig. S1; for
description of all GFP-based organelle markers see Methods). A
minor effect was observed for mitochondria, which showed a
tendency to undergo fragmentation (Fig. S1). However, terbin-
afine did induce a dramatic reorganization of the endoplasmic
reticulum. Control cells treated with the solvent dimethyl sulfoxide
(DMSO; Fig. 1A, S1) showed a peripheral network of endoplas-
mic reticulum tubules, which corresponded well with previous
reports in untreated cells [24]. Treatment of cells with 50 mg/ml
terbinafine led to the formation of globular endoplasmic reticulum
structures (Fig. 1A,5 0 mg/ml TBF; Fig. 1B, 1C). Globular,
endoplasmic reticulum structures were also induced by treatment
of cells with terbinafine-loaded TFVs, but the effect occurred at
much lower concentrations of terbinafine (Fig. 1A,2 0mg/ml,
TBF in TFVs; Fig. 1B; Movie S1). Conventional terbinafine had
no obvious effect at this concentration (Fig. 1A,2 0mg/ml, TBF;
Fig. 1B). The globular endoplasmic reticulum structures appeared
as membrane aggregations under electron microscopy (Fig. 1D),
suggesting that terbinafine interferes with the membrane organi-
zation of the endoplasmic reticulum.
TransfersomeH vesicles penetrate the fungal cell
To investigate whether the TFVs can enter the fungal cell, TDT
067 was used that was labeled with 1,6-diphenyl-1,3,5-hexatriene,
a dye that specifically labels lipid membranes [25]. Scanning
electron microscopy of these fluorescent terbinafine-loaded TFVs
indicated that the applied suspension contained vesicles of various
sizes (Fig. 2A). This size variation was also found when non-
fluorescent TFVs were visualized in scanning electron microscopy
(not shown). However, using photon correlation spectroscopy
TFVs were found to be of uniform size, with an average diameter
of ,90 nm and a size distribution width of 15 nm (Dr. U. Vierl,
C.P.M. ContractPharma GmbH & Co. KG, Feldkirchen-Wester-
ham, Germany, pers. communication), suggesting that the size
variation observed in my experiments are most likely due to
dehydration occurring during the preparation process.
When applied to U. maydis hyphae, the fluorescent terbinafine-
loaded TFVs induced the formation of characteristic structures
within 15–30 min (Fig. 2B; ‘‘Control’’ indicates untreated cells;
‘‘TFVs’’ indicates TransfersomeH treatment for 30 minutes; new
structures indicated by asterisks). These structures were globular
and strongly fluorescent (Fig. 2C, 15 min; Movie S2), demon-
strating that they were derived from uptake of fluorescently labeled
terbinafine-loaded TFVs. The same phenotype was observed
when terbinafine-free fluorescent TFVs were applied (not shown).
The kinetics of this uptake was investigated by measuring the
average fluorescent intensity along several micrometers in
terbinafine-loaded TransfersomeH-treated hyphae. Almost no
fluorescent signal was detected before the terbinafine-loaded
TransfersomeH suspension was applied (Fig. 2C, 0 min;
Fig. 2D); however, spots of fluorescence appeared shortly after
incubation (Fig. 2C, 1 min; Fig. 2D) and strongly labeled
globular structures were observed after 15–30 min of incubation
(Fig. 2C, 15 min; Fig. 2D). Interestingly, the increase in
fluorescent intensity reached a maximum value after 15–20 min
Table 1. Genotype of strains and plasmids used in this study.
AB33 a2 PnarbW2 PnarbE1 ble
R [80]
AB33GLAct a2 PnarbW2 PnarbE1 ble
R/poGLifeAct [39]
AB33G3Dyn2 a2 Pnar-bW2 Pnar-bE1,
Pdyn2-3xegfp-dyn2, ble
R, hyg
R
[79]
AB33GRab5a a2 PnarbW2 PnarbE1, ble
R/poGRab5a [79]
AB33ERG a2 PnarbW2 PnarbE1, ble
R/pERGFP [24]
AB33GSKL a2 PnarbW2 PnarbE1, ble
R/poGSKL [42]
AB33LgaG a2 PnarbW2 PnarbE1, ble
R/poLgaG [42]
AB33CpYG a2 PnarbW2 PnarbE1, ble
R/poCpyG This
study
AB33nG a2 PnarbW2 PnarbE1, ble
R/pnGFP This
study
poGLifeAct Potef-egfp-ABP140
1-17_modified cbx
R [39]
poGRab5a Potef-egfp-rab5a, nat
R [30]
pERGFP Potef-cal
s-gfp-HDEL, cbx
R [24]
poGSKL Potef-egfp-SKL, cbx
R [42]
poLgaG Potef-lga-egfp, cbx
R [42]
poCpYG Potef-cpY-gfp, nat
R This
study
pnGFP gal4(s):egfp, cbx [78]
a, b, mating type loci; P, promoter; -, fusion; hygR, hygromycin resistance; bleR,
phleomycin resistance; natR, nourseothricin resistance; cbxR, carboxin
resistance/, ectopically integrated; otef, constitutive promoter; nar, conditional
nitrate reductase promoter; E1, W2, genes of the b mating type locus; LifeAct,
first 17 aa of Abp140 dyn2: C-terminal half of the dynein heavy chain; rab5a,
small endosomal Rab5-like GTPase; cpy, carboxy-peptidase Y; calS, signal
sequence of calreticulin from rabbit, HDEL, endoplasmic reticulum retention
signal; gal4s, nuclear localization signal of the GAL-4 DNA binding domain from
pC-ACT1 (Clontech); SKL, peroxisomal targeting signal; lga2, putative
mitochondrial matrix protein.
doi:10.1371/journal.pone.0038181.t001
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maximum capacity for uptake or cellular presence of the
fluorescent terbinafine-loaded TFVs.
Next we set out to capture the moment of uptake by fixing cells
shortly after applying TFVs was addressed. Transmission electron
microscopy revealed small vesicles of about 50–80 nm attached to
the outer fungal cell wall (Fig. 2E, insets and arrowheads;
Fig. 2F), which most likely are TFVs that were fixed during
invasion of the fungal cell. It was observed that these vesicles were
usually elongated (Fig. 2E, inset in the lower right corner;
Fig. 2G) and occasionally deformed (Fig. 2F, arrowhead). This
corresponds well with the previously described capacity of TFVs to
undergo extreme curvature [5,6].
The entry of the TransfersomeH into fungal cells is
dependent on the concentration of Tween 80 in the
vesicle membrane
To test for the importance of the concentration of Tween 80 in
the TransfersomeH, fluorescently labeled TransfersomeH suspen-
sions were generated that varied in the ratio of phosphatidylcho-
line to Tween 80, ranging from 2:1 (the standard ratio used in
most experiments) to 20:1 (provided by Dr. U. Vierl, C.P.M.
ContractPharma GmbH & Co. KG, Feldkirchen-Westerham,
Germany). Control experiments demonstrated that the variation
in Tween 80 concentration did not affect the size and shape of the
vesicles when prepared for scanning electron microscopy (Fig. 3A;
phosphatidylcholine to Tween 80 ratio indicated by ‘‘2:1’’ and
‘‘20:1’’). When applied to fungal hyphae, 2:1 terbinafine-loaded
TFVs rapidly appeared in the fungal cells and accumulated in the
described globular fluorescent structures (Fig. 3B, 2:1, left panel).
In contrast, low concentration of Tween 80 prevented uptake of
the fluorescent vesicles (Fig. 3B, 20:1, middle panel) and only few
faint signals were observed (Fig. 3B, 20:1, right panel; note that
image ‘‘right panel 2:1’’ and ‘‘middle panel 20:1’’ were identically
scaled and processed; the image ‘‘20:1 left panel’’ was contrast and
brightness processed and gamma-values were adjusted to visualize
the faint fluorescent signals). The difference in appearance of
fluorescent signals is most obvious in comparative line scan
Figure 1. The effect of terbinafine and terbinafine-loaded fluorescent TFVs on the endoplasmic reticulum. (A) The organization of the
endoplasmic reticulum (labeled with a green fluorescent protein fused to an ER-retention signal and an ER targeting sequence [24]; see Methods) in
hyphae treated with the solvent dimethyl sulfoxide (DMSO), terbinafine encapsulated in fluorescent TFVs (TBF in TFVs), and pure terbinafine (pure
TBF). Globular endoplasmic reticulum structures were formed after 30-min treatment with 20 mg/ml terbinafine applied in TransfersomeH suspension
(see also Movie S1). Similar structures occurred when cells were treated with 50 mg/ml terbinafine. Bar represents micrometers. (B) Graph showing
the proportion of cells with normally organized endoplasmic reticulum in cells treated with terbinafine or terbinafine-loaded TFVs (TFVs). (C) Detail of
a globular endoplasmic reticulum structure after treatment with 50 mg/ml terbinafine. The ER structure was labeled with a green fluorescent protein
fused to an ER-retention signal and an ER targeting sequence [24]. Bar represents a micrometer. (D) Electron micrograph of globular membrane
accumulation in TFVs-treated cells. Bar represents a micrometer.
doi:10.1371/journal.pone.0038181.g001
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images (Fig. 3C).
Next the uptake kinetics of fluorescent terbinafine-loaded TFVs
at phosphatidylcholine to Tween 80 ratios of 2:1, 5:1, 10:1, and
20:1 was investigated. Again, it was found that the standard 2:1
TFVs were rapidly taken up and reached a plateau of maximal
fluorescence intensity after 15–20 min (Fig. 3D, 2:1). In contrast,
very little fluorescence appeared when the concentration of Tween
80 in the TransfersomeH membrane was reduced (Fig. 3D, 5:1,
10:1, 20:1), suggesting that these TFVs were not able to enter the
fungal cell. Indeed, no globular structures were observed in
electron micrographs of hyphae treated with 20:1 fluorescent
terbinafine-loaded TFVs (not shown). These results indicate that
high concentrations of Tween 80 are required to enable the
Figure 2. Entry of terbinafine-loaded TFVs into the fungal cell. (A) Scanning electron micrograph of terbinafine-loaded TransfersomeH
vesicles. Bar represents micrometers. (B) Electron micrographs of an untreated hyphal cell (control) and after 30 min of incubation with fluorescent
terbinafine-loaded TFVs (TBF in TFVs). The cell accumulates large droplets (asterisk). Bar represents micrometers. (C) Uptake of fluorescently labeled
terbinafine-loaded TransfersomeH vesicles. Prior to TransfersomeH treatment, the cells show weak background fluorescence (0 min). Small and
relatively faint fluorescent signals appear ,1 min after adding fluorescent TFVs (1 min) and strong fluorescence is detected after ,15 min of
incubation. See also Movie S2. Bars represent micrometers. (D) Graph showing the kinetics of TransfersomeH uptake. Each data point represents the
mean 6 standard error of the mean of 10–17 measurements. Note that uptake is rapid (KK ,2 min) and that uptake reaches a maximum (green
dotted line). (E) Electron micrograph showing vesicles (arrowheads) attached to a hyphal cell treated with fluorescent terbinafine-loaded TFVs. Note
that the attached vesicles are elongated (right lower corner). Bars represent micrometers. (F) Image series of electron micrographs of TFVs at different
stages of entry. Note the deformation of the vesicles. Bar represents micrometers. (G) Bar chart showing the length and the width of vesicles attached
to the outer fungal cell wall. Note that only those structures were measured that showed a lumen (e.g. the upper two vesicles in the image series
given in F). Mean 6 standard error of the mean of 16 measurements. Statistical significance difference at P,0.001 is indicated by double asterisks.
doi:10.1371/journal.pone.0038181.g002
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Transfersomes passing through the skin where lower concentra-
tions are sufficient to take the vesicles through and the operating
range is wider.
We noted that hyphal cells treated with low-Tween 80 TFVs
often showed sheet-like fluorescent patches (Fig. 3E). These
fluorescent patches appeared at the periphery of the cell (Fig. 3E,
inset, contrast was inverted for better visualization), suggesting that
they represent TFVs that were attached to the fungal cell wall but
did not enter the cell. This possibility was tested using scanning
electron microscopy. Hyphal cells that were treated with the
standard 2:1 terbinafine-loaded TFVs showed few attached
structures which were too small to be resolved as vesicles
(Fig. 3F). In contrast, a reduced Tween 80 concentration enabled
attachment of the vesicles to the fungal cell wall (Fig. 3F). At a
higher magnification in transmission electron microscopy, large
patches of vesicles were observed attached to the fungal cell wall
(Fig. 3G, 20:1) that matched the peripheral patches of fluores-
cence (Fig. 3G, inset). These data suggested that Tween 80 is
required to overcome the fungal cell wall. This conclusion is
Figure 3. The effect of Tween 80 concentrations on TransfersomeH uptake. (A) Scanning electron micrographs showing fluorescent
terbinafine-loaded TFVs with the standard phosphatidylcholine to Tween 80 ratio (2:1) and at 10-times reduced Tween 80 concentration (20:1). Both
vesicle carriers show a similar appearance. Bar represents micrometers. (B) Cellular fluorescence of TransfersomeH-derived lipids after 30 min of
incubation with standard fluorescent terbinafine-loaded fluorescent TFVs (2:1) and fluorescent terbinafine-loaded fluorescent TFVs with a 10-times
lower concentration of Tween 80 (20:1). Treatment with the latter resulted in very little cellular fluorescence and only a few faint signals were
detected (right panel). Note that image ‘‘right panel, 2:1’’ and ‘‘middle panel, 20:1’’ were identically scaled and processed using MetaMorph. The
image ‘‘20:1, left panel’’ was contrast and brightness processed and gamma-values were adjusted to visualize the faint TransfersomeH-derived
fluorescent signals. Bar represents micrometers. (C) Intensity profile of fluorescent signals in hyphae treated with standard fluorescent terbinafine-
loaded TFVs (2:1) and fluorescent terbinafine-loaded TFVs with a 10-times lower concentration of Tween 80 (20:1). (D) Graph showing the uptake
kinetics of fluorescent TFVs with various ratios of Tween 80 to phosphatidylcholine (2:1, 5:1, 10:1, 20:1). Uptake of TFVs depends on a high
concentration of Tween 80 in their membrane. (E) Fluorescent patches at the periphery of hyphal cells treated with fluorescent vesicles at a 10:1 ratio
of Tween 80 to phosphatidylcholine. Inset shows a contrast inverted image. Note that similar patches were found in experiments using 5:1 and 20:1
phosphatidylcholine to Tween 80 ratios. Bar represents micrometers. (F) Scanning electron micrographs showing hyphal cells treated with
fluorescent terbinafine-loaded TFVs at a 2:1 and 20:1 ratio of Tween 80 to phosphatidylcholine. Vesicles attach to the hyphal surface at a lower
concentration of Tween 80, suggesting that Tween 80 reduces unspecific binding of TransfersomeH membranes to the cell wall. Bars represent
micrometers. (G) Transmission electron micrograph of hyphal cells treated with fluorescent terbinafine-loaded TFVs at a 20:1 ratio of Tween 80 to
phosphatidylcholine. Numerous small vesicles are attached to the cell wall. Inset shows a uniform fluorescent rim at the surface of a cell which most
likely corresponds to the lawn of attached vesicles shown in the electron micrograph. Bars represent micrometers.
doi:10.1371/journal.pone.0038181.g003
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wall free protoplasts, although significantly less fluorescence was
measured inside protoplasts when compared to the standard 2:1
TFVs (P=0.0008, two-tailed t-test; Fig. S2, 2:1 and 20:1). Taken
together, these data indicate that the level of Tween 80 is
important for the activity of the TransfersomeH against the fungus
as it allows hyper-deformation of the vesicle membrane which is
required for it to pass through the small holes in the fungal cell
wall. In addition, Tween 80 appears to reduce unspecific
interaction of the vesicles with the fungal cell wall, which might
hinder the entry into the cell.
Entry of terbinafine-loaded TransfersomeH vesicles into
the fungal cell is a passive process
It was reported that whole vesicles can cross the fungal cell wall
[26,27], which raises the possibility that Transfersome vesicles
enter the fungal cell via the endocytic pathway. Uptake of material
into the fungal cell by endocytosis has been shown to occur in
various filamentous fungi [28–31], including U. maydis [32,33].
The process of endocytosis is dependent on F-actin patches that
mark the region of endocytic uptake [34]. In fungi, these patches
can be visualized using a green fluorescent protein (GFP)-based
probe lifeAct-GFP [35–37]; overview in [38]. In U. maydis, lifeAct-
GFP labels cables and endocytic patches (Fig. 4A, upper panel;
[39]). The use of 10 mM latrunculin A (a specific inhibitor of F-
actin [40]) destroyed these F-actin structures in U. maydis (Fig. 4A,
lower panel; [41]), which is predicted to block endocytosis.
However, in latrunculin A-treated hyphae, terbinafine-loaded
fluorescent TFVs were still taken up into the fungal cells (Fig. 4B).
To confirm that endocytosis was blocked under these conditions,
co-staining of TFVs with the lipophilic endocytic marker dye
FM4-64 was done. Indeed, disruption of F-actin by latrunculin A
abolished the concentration of FM4-64 in the vacuole membrane
and instead the dye remained in the plasma membrane (Fig. 4C,
PM). In contrast, the dye accumulates in vacuoles when cells were
treated with the solvent dimethyl sulfoxide (DMSO; Fig. 4C, V).
This result confirms that F-actin is required for endocytic uptake
of FM4-64 into the fungal cell. However, fluorescent Transfer-
someH-membranes accumulate in the cytoplasm of latrunculin A -
treated, again indicating the TransfersomeH uptake occurs
independently of the endocytic pathway.
To determine if terbinafine-loaded TFVs reach the fungal
vacuole, where the content of endocytic vesicles is known to be
deposited [33], we co-localized TransfersomeH-derived fluorescent
signals with the early endosome marker GFP-Rab5a [32] and with
a vacuolar marker carboxy-peptidase Y-GFP [42]. We did not
observe co-localization of fluorescent terbinafine-loaded TFVs and
early endosomes or vacuoles, respectively (Fig. 4D, 4E; Fig. S3).
This also argues against an endocytic uptake of TransfersomeH
vesicles.
Finally, the site of uptake of fluorescent terbinafine-loaded
TFVs into the fungal hyphal cell was monitored. As recent work
has demonstrated that endocytosis occurs predominantly near the
growing cell tip [29], we expected high fluorescence near the
hyphal tip, which would indicate that the TFVs enter the cell via
endocytosis. To test this, we incubated hyphal cells for 1 min and
30 min and performed an intensity scan along the length of the
hyphal cell. We found that fluorescent signals appeared along the
entire cell shortly after adding the TFVs and no concentration was
detected near the hyphal tip (Fig. 4F). This strengthens our
argument against a role for endocytosis in TransfersomeH uptake.
TransfersomeH membranes form lipid droplets
Treatment with fluorescent terbinafine-loaded TFVs results in
the appearance of cytosolic fluorescent signals, suggesting that the
vesicles enter the fungal cell. The first signals appeared a few
minutes after TFVs application, and were relatively faint and of
even intensity (Fig. 5A, upper panel; Fig. 5B, upper graph). With
time, these signals unevenly increased in sensitivity (Fig. 5A, lower
panel; Fig. 5B, lower graph; see also above Fig. 4F). The
strongest globular signals had diameters of up to 700 nm and
appeared solid in electron micrographs (Fig. 5C; see above
Fig. 2B). This suggests that they are not accumulations of hollow
and intact TFVs. Electron micrographs also demonstrated that the
fluorescent terbinafine-loaded TransfersomeH-induced globular
structures are surrounded by a single membrane (Fig. 5D; solid
arrowhead; compare with double membrane of a vacuole
indicated by open arrowhead). This is characteristic of lipid
droplets [43], raising the possibility that these structures are lipid
bodies that derived from fused TransfersomeH membranes. To test
the nature of the globular bodies, we stained terbinafine-loaded
TransfersomeH-treated hyphal cells with the lipid dye Nile Red
[44]. Indeed, we found a clear co-localization of the Nile Red with
the fluorescent TransfersomeH-derived structures (Fig. 5E). This
suggests that these bodies are indeed lipid droplets. To gain further
support for this conclusion, we generated cell-wall less protoplasts
from fluorescent terbinafine-loaded TransfersomeH-treated cells
and disrupted them by osmotic shock. Structures of high retractile
index were observed that showed a strong 1,6-diphenyl-1,3,5-
hexatriene fluorescence (Fig. 5F). The optical features of the
fluorescent droplets confirmed the notion that these fluorescent
globular bodies are indeed lipid bodies.
TransfersomeH-derived lipid bodies are enzymatically
degraded by lipases
The appearance of lipid droplets suggested that TFVs were
degraded after entry into the cell. This notion was supported by
uptake kinetics that demonstrated a maximum plateau after
15 min (see above), suggesting that the lipid droplets degradation
balances the intake. To gain experimental support for this
conclusion, a pulse-chase experiment was performed. For this
fungal cells were incubated for 20 minutes with Terbinafine-
loaded fluorescent TFVs, the amount of cytosolic fluorescence was
measured and the cells were transferred into TransfersomeH-free
medium for an additional 30 minutes. In these experiments, the
number of TransfersomeH-derived lipid bodies was significantly
reduced (Fig. 6A) and that the associated fluorescence dropped
(Fig. 6B). These results suggested that the cellular capacity for
TFVs is determined by the activity of lipid-degrading enzymes.
This was further tested by incubating hyphae with fluorescent
terbinafine-loaded TFVs in the presence of the ionophore cyanide
3-chlorophenyl-hydrazone (CCCP). This inhibitor reversibly
blocks cell respiration, resulting in reduced ATP levels [45]. The
effect on U. maydis was blocking motility of fluorescently labeled
dynein motors. In the presence of the solvent DMSO, dynein
motors were rapidly moving along microtubules, which is known
to be an ATP-dependent process [46]. In the presence of 100 mg/
ml CCCP, all motility stopped within 30–45 min (Movie S3; Fig.
S4). This confirmed that treatment with the ionophore led to a
depletion of cellular ATP levels. When cells were incubated with
CCCP or DMSO and fluorescent terbinafine-loaded TFVs,
fluorescent signals were detected inside the fungal cells (Fig. 6C),
again arguing that TransfersomeH uptake is a passive process.
However, ATP-depleted cells showed significantly stronger fluo-
rescent signals than control cells (Fig. 6D), which is consistent
with the notion that the terbinafine-loaded TFVs are a substrate
Fungal Lipases Release Content from Transfersomes
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plasm. In summary, these experiments indicate that TFVs and
lipid bodies are substrates for ATP-dependent enzymatic degra-
dation.
A lipase inhibitor prevents degradation and neutralizes
the antifungal activity of terbinafine-loaded
TransfersomeH
The ATP dependency of the degradation of TransfersomeH-
derived lipids suggested some metabolic activity of fungal lipases
[47,48]. We screened the published genome of U. maydis (http://
mips.gsf.de/genre/proj/ustilago/) and identified 21 potential
lipases. Nine of these contain a secretion signal and might act
outside the cell (predicted by http://www.cbs.dtu.dk/services/
TargetP/); two are predicted to locate within mitochondria; and
one lipase contains a PX-like domain (predicted by http://www.
ebi.ac.uk/interpro/), suggesting that it binds to the lipids of early
endosomes [49]. The remaining nine lipases could be cytosolic and
have the potential to act on the TransfersomeH membranes. To
test this lipase activity was inhibited by specific inhibitors and the
effect on TransfersomeH-degradation was monitored. Cells were
incubated with fluorescent TFVs, followed by extended incubation
in TransfersomeH free medium that was supplemented with the
solvent DMSO and the specific lipase inhibitors Orlistat [50] and
URB602 [51,52]. The degradation of fluorescent terbinafine-
loaded TransfersomeH-derived lipids occurred in DMSO and in
the presence of the gastric and pancreatic lipase inhibitor Orlistat,
but was strongly inhibited when lipases were inhibited by a
monoacylglycerol inhibitor URB602 (Fig. 7A, 7B). This result
added further support to the notion that terbinafine-loaded TFVs
are a substrate for cytosolic lipid-degrading enzymes.
On the basis of these results, we investigated whether attack by
lipase activity is responsible for the release of terbinafine from the
TFVs. To test this we monitored the antifungal activity of
fluorescent terbinafine-loaded TFVs in the presence of the lipase
inhibitor URB602. Treatment with 30 mg/ml terbinafine in TFVs
led to collapse of endoplasmic reticulum membrane structures in
almost all cells (Fig. 7C; see also Fig. 1B). However, in the
presence of 50 mM URB602, terbinafine-loaded TransfersomeH
suspension had no effect on the endoplasmic reticulum organiza-
tion (Fig. 7C). Even treatment with 100 mg/ml terbinafine in
TFVs only led to minor disruption of the endoplasmic reticulum
organization when lipases were inhibited (Fig. 7C, right panel).
Figure 4. Evidence against endocytic uptake of TransfersomeH vesicles. (A) A hyphal cell showing F-actin structures labeled with lifeAct-GFP
in the presence of the solvent DMSO (control) and in the presence of 10 mM of the actin inhibitor latrunculin A (LatA). Note that latrunculin A disrupts
endocytic F-actin patches and F-actin cables. Bar represents micrometers. (B) Uptake of fluorescently labeled terbinafine-loaded TFVs (TLT) after
30 min of incubation in the absence of F-actin patches (background fluorescence is due to unbound GFP-LifeAct protein [35–37]). Note that uptake
occurs at normal rates, demonstrating that F-actin is dispensable for entry of the vesicles into the fungal cell. Bar represents micrometers. (C) Co-
localization of fluorescent terbinafine-loaded TFVs (blue, TLT) and the endocytic marker dye FM-64 (red) in the presence of the solvent dimethyl
sulfoxide (DMSO) or Latrunculin A (LatA). In control cells the marker dye FM4-64 concentrates in vacuoles (V), whereas disruption of the F-actin
cytoskeleton abolishes endocytic uptake and the dye remains in the plasma membrane (PM). In both cases, TFVs accumulate in the cytosol. Bar
represents micrometers, (D) Localization of fluorescent terbinafine-loaded TFVs (red, TLT) and carboxypeptidase Y (green, CPY), a marker for vacuoles.
Note that both structures do not co-localize. Bar represents micrometers. (E) Localization of fluorescent terbinafine-loaded TFVs (red, TLT) and the
small GTPase Rab5a (green, Rab5a), a marker for early endosomes. Note that both structures do not co-localize. Bar represents micrometers. (F) Graph
showing fluorescent intensity scans along the hyphal cell at 1 min and 30 min after treatment with fluorescent terbinafine-loaded TFVs. Note that
endocytosis is expected to occur at the hyphal tip only (indicated by ‘‘Endocytosis’’), whereas fluorescent signals occur along the entire cell.
doi:10.1371/journal.pone.0038181.g004
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terbinafine-loaded TFVs, as fluorescent signals were found within
the fungal cells (Fig. 7D). These data add support to the
conclusion that TFVs are digested by cytosolic fungal lipases. This
activity appears to release the enclosed antifungal within the fungal
cell.
Discussion
Terbinafine affects the organization of the fungal
endoplasmic reticulum
Terbinafine is a well-characterized drug that is known to inhibit
squalene epoxidase, a key enzyme in the ergosterol and cholesterol
Figure 5. Characterization of fluorescently labeled TransfersomeH-derived structures. (A) Images showing hyphal cells that were
incubated for 5 min (upper panel) and 30 min (lower panel) with fluorescent terbinafine-loaded TransfersomeH vesicles. Note that at early stages
fluorescent signals are small and even in intensity, whereas signals become larger and differ in intensity with time. Note also that the difference in
intensity between the upper and lower panel are not representative due to image processing (for comparison of intensities see panel B). Bar
represents micrometers. (B) Graphs showing fluorescent intensity scans along the hyphal cells treated with fluorescent terbinafine-loaded TFVs for
5 min (upper graph) and 30 min (lower graph). At 5 min, the signals are faint (,3000 arbitrary units) and even in intensity (blue dotted line), whereas
signal intensity increases with time (lower graph; up to ,12000 arbitrary units) and becomes unevenly distributed (blue dotted line). (C) Electron
micrograph showing intracellular structures after treating cells with fluorescent terbinafine-loaded TransfersomeH vesicles for 30 min. Bar represents
micrometers. (D) Electron micrograph showing a vacuole and a TransfersomeH-derived structure. The vacuole is surrounded by a double membrane
(red arrowhead), whereas the TransfersomeH-derived structure -derived structure is surrounded by a single membrane, suggesting that it represents
a lipid droplet. Bar represents micrometers. (E) Co-localization of fluorescent structures (TLS) and the lipid marker dye Nile Red (Nile Red). Bar
represents micrometers. (F) Lipid structures derived from osmotically disrupted protoplasts of fungal cells treated with fluorescent TFVs for 30 min.
After breaking the wall-less cells, structure of high contrast remain (upper panel, DIC) that show strong 1,6-diphenyl-1,3,5-hexatriene fluorescence
(lower panel, DBH). The high retractile index of the globular structures indicates that the fluorescent structures are lipid droplets. Bar represents
micrometers.
doi:10.1371/journal.pone.0038181.g005
Figure 6. Evidence for an ATP-dependent degradation of fluorescent terbinafine-loaded TFVs. (A) Images showing hyphal cells that
were incubated for 30 min with fluorescent terbinafine-loaded TFVs, washed twice and immediately observed (0 min) or incubated for an additional
30 min at room temperature (30 min). Note that the cellular fluorescence decreases with time. Bar represents micrometers. (B) Bar chart showing
average signal intensities in hyphal cells that were incubated for 30 min with fluorescent terbinafine-loaded TFVs, washed twice and immediately
observed (0 min) or incubated for an additional 30 min at room temperature (30 min). Bars represent mean 6 standard error of the mean of 23
(0 min) and 32 (30 min) measurements. Statistical significance difference at P,0.0001 is indicated by triple asterisks. (C) Images showing hyphal cells
that were incubated for 30 min with fluorescent terbinafine-loaded TFVs in the presence of the solvent DMSO and 100 mg/ml of the ionophore CCCP,
which depletes cellular ATP levels. Bar represents micrometers. (D) Images showing hyphal cells that were incubated for 30 min with fluorescent
terbinafine-loaded TFVs in the presence of the solvent DMSO and 100 mg/ml of the ionophore CCCP. Bars represent mean 6 standard error of the
mean of 13 (DMSO) and 15 (CCCP) measurements. Statistical significance difference at P,0.0001 is indicated by triple asterisks.
doi:10.1371/journal.pone.0038181.g006
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afine is particularly potent against fungal enzymes, but has only
minor activity against squalene epoxidase from rat liver [53].
Therefore, terbinafine is a valuable antifungal agent that is
particularly effective in the treatment of dermatophyte onycho-
mycosis [15,54]. Fungal-specific ergosterol is found in the plasma
membrane where it is involved in numerous processes, including
endocytosis [55], and cell–cell fusion during mating [56].
However, it also resides in other organelles (e.g. mitochondria,
vacuoles/lysosome, endoplasmic reticulum), where it might
support other essential and more unexpected functions (e.g.
maintaining pH homeostasis at the vacuolar membrane [57]). As
part of the fungal membrane, ergosterol determines membrane
fluidity and sub-domain organization (e.g. formation of lipid rafts
[58,59]).
In our experiments, terbinafine caused a collapse of the
endoplasmic reticulum in U. maydis. In the budding yeast S.
cerevisiae, inhibition of ergosterol synthesis causes the influx of
calcium into the endoplasmic reticulum [60], which raises the
possibility that the observed collapse of the endoplasmic reticulum
could be an indirect consequence of a change in ion homeostasis.
Altered calcium homeostasis resulted in alteration of the fungal
microtubule cytoskeleton [61,62], but no effect on the organiza-
tion of the endoplasmic reticulum was reported. Thus, it seems
unlikely that changes in calcium levels caused the loss of
endoplasmic reticulum organization we observed in our study.
Alternatively, it is possible that inhibition of ergosterol synthesis by
terbinafine alters the membrane properties of this compartment,
thereby causing the observed collapse of the endoplasmic
reticulum tubules. Ergosterol biosynthesis has been shown to be
involved in mitochondria and vacuole organization [63,64],
illustrating that those membrane lipids can play crucial roles in
maintaining the morphology of organelles. The endoplasmic
reticulum is known to consist of sub-domains and its sub-cellular
organization is essential for its cellular function [65]. Thus, the
terbinafine-induced collapse of the endoplasmic reticulum network
is predicted to interfere with its essential function, which might
account in part for the antifungal activity of terbinafine.
Entry of terbinafine-loaded TransfersomeH vesicles into
the fungal cell requires the surfactant Tween 80
Our data show that fluorescent terbinafine-loaded TFVs rapidly
enter the fungal cell. To do this, the vesicles have to overcome the
extracellular fungal cell wall and the underlying plasma mem-
Figure 7. Inhibition of terbinafine-loaded TransfersomeH degradation and cytotoxicity by lipase inhibitors. (A) Images showing hyphal
cells treated with fluorescent terbinafine-loaded TFVs for 30 min, followed by incubation in TransfersomeH-free conditions in the presence of the
solvent DMSO (+DMSO) and the lipase inhibitor URB602. Bar represents micrometers. (B) Graph showing average fluorescent intensity in hyphal cells
treated with fluorescent terbinafine-loaded TFVs for 30 min, followed by incubation in TransfersomeH-free conditions in the presence of the solvent
DMSO (+DMSO) and the lipase inhibitors Orlistat and URB602. Bars represent mean 6 standard error of the mean of 18–30 measurements per data
point. Statistical significance difference at P,0.001 is indicated by double asterisks; triple asterisks indicate difference at P,0.0001. (C) Images
showing the defect in organization of the endoplasmic reticulum in the presence of 30 mg/ml terbinafine encapsulated in fluorescent TFVs (TLT) and
the solvent DMSO, 30 mg/ml terbinafine encapsulated in fluorescent TFVs and 50 mM of the lipase inhibitor URB602, and 100 mg/ml terbinafine
encapsulated in fluorescent TFVs and 50 mM of the lipase inhibitor URB602. Note that the lipase inhibitor prevented the induction of collapsed
endoplasmic reticulum structures (see above Fig. 1) even at high TransfersomeH concentrations. Bar represents micrometers. (D) Fungal cells treated
with fluorescent TFVs for 30 min in the presence of 50 mM of the lipase inhibitor URB602. Small fluorescent signals appear inside the hyphal cells but
no collapsed endoplasmic reticulum structures are visible, indicating that the terbinafine-loaded vesicles enter the cell, but the presence of the lipase
inhibitor prevents release of the drug and thereby inhibits the cytotoxicity of the TransfersomeH carriers. Bar represents micrometers.
doi:10.1371/journal.pone.0038181.g007
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polysaccharides and manno-proteins [66]. In Cryptococcus neofor-
mans, the cell wall restricts passage of macromolecules larger than
270 kDa, which corresponds to a pore size of ,10 nm [67].
Microscopic methods have shown that most pores are even smaller
than this and only few openings extended to 30 nm [68]. The
TFVs have an average diameter of ,90 nm (Dr. U. Vierl, C.P.M.
ContractPharma GmbH & Co. KG, Feldkirchen-Westerham,
Germany, pers. communication) and therefore the fungal cell wall
is an almost insurmountable obstacle for the vesicular drug
carriers. However, the results presented in this study show that
small fluorescent terbinafine-loaded TFVs rapidly overcome this
barrier and enter the fungal cell. This is most likely related to their
ability to deform, which is due to the presence of membrane-
softening surfactants [1,5,6]. Indeed, we show that reduction of the
non-ionic surfactant Tween 80 abolished uptake of TFVs. Instead,
the drug carriers attached to the cell wall and formed patch-like
fields of vesicles that appeared to make contact with the surface
but failed to pass through the cell wall. This result suggests that the
Tween 80 concentration is important in penetrating hyphae. Most
likely, the high concentration of Tween 80 is required to allow
ultra-deformation of the vesicles.
One other scenario need to be considered. Atomic force
microscopy studies on cell walls of living budding yeast cells have
demonstrated the presence of very large pores ranging from 50–
250 nm [69]. In addition, evidence for outward transport of intact
vesicles through the cell wall of C. neoformans exist [26], suggesting
that the fungal cell wall is more permeable than currently
anticipated [overview in 27], which would allow the passage of
TFVs without extreme deformation. We were not able to observe
vesicles or pores in the cell wall of U. maydis, which makes such
extracellular membrane trafficking in this fungus unlikely.
However, even in the case those TDT 067 vesicles invade via
large pores, our results show that presence of Tween 80 is required
for cell invasion. In this scenario the detergent might avoid an
unspecific interaction of the hydrophilic vesicles with the surface of
the fungus, which could prevent passage of the vesicles through the
cell wall. Such activity of Tween 80 was reported for in vitro assays,
where the surfactant minimizes non-ionic adsorption of viruses to
membranes, thereby enhancing passage of the particles through
nitrocellulose membranes [70].
We were not able to recognize intact TFVs in the cytoplasm of
U. maydis, which might be due to a rapid digestion of the incoming
vesicle (see below). However, the results summarized here
demonstrate that TransfersomeH-derived lipids accumulate in
the cytoplasm of U. maydis. This finding strongly suggests that the
vesicles, once having passed through the fungal cell wall, overcome
the plasma membrane. A standard way of particle uptake into
eukaryotic cells is endocytosis, which has also been reported for
filamentous fungi [28,29,32,33,71], overview in [30,31] and [72].
Endocytosis occurs predominantly at the hyphal tips where F-actin
patches are formed that support the formation and uptake of an
endocytic vesicle [29,34; overview in 38]]. This paper demon-
strates that entry of TFVs occurs along the whole length of the
fungal cell and is F-actin-independent. Moreover, the formation of
TransfersomeH-derived lipid droplet occurs under ATP-depleted
conditions. Thus, TransfersomeH entry to the fungus is ATP- and
F-actin-independent, which makes the involvement of the
endocytic machinery in their uptake unlikely. The question
remains how TFVs cross the plasma membrane. At present we
can only speculate on this. Non-enveloped viruses overcome host
membranes by a mechanism called membrane penetration [73],
which allows passage of intact viral particles of ,50 nm in
diameter through membranes in an endocytosis-independent
manner [74]. The molecular basis of this mechanism is not
understood [75], but we consider it possible that TFVs could adapt
similar strategies to overcome the fungal plasma membrane.
Cytoplasmic lipases release terbinafine from the
TransfersomeH vesicles
Once in the cytoplasm, the terbinafine-loaded TFVs have to
release the terbinafine to exert its antifungal activity. In ultra-
structural studies, vesicular structures in the fungal cytoplasm were
ever observed, but instead globular bodies were seen that are most
likely lipid droplets. Similar bodies were reported for dermato-
phytes treated with TDT 067 [20]. In our experiments, these lipid
droplets concentrate the TransfersomeH membrane-associated
fluorescence and appear shortly after application of the vesicles.
However, the increase in fluorescence follows Michaelis–Menten
kinetics, suggesting that the presence of the lipid bodies is related
to enzymatic activity. Indeed, when ATP levels were reduced by
treatment with the ionophore CCCP [45], significantly more lipid-
associated fluorescence was detected, which confirms the notion
that active cellular processes limit the amount of TFVs in the cell.
In pulse-chase experiments, where the supply of TFVs was
removed after an initial phase of treatment, the amount of lipid
droplets decreased with time. This strongly argues that Transfer-
someH-derived lipid droplets are digested by fungal lipid-degrad-
ing enzymes. An important class of lipid-hydrolyzing enzymes are
lipases, which are prominent in fungi [47,48]. The genome of U.
maydis contains 21 predicted lipases, among which we found
numerous candidates for cytosolic lipases, including homologues of
the cytosolic hormone-sensitive lipase (um06274) or phospholipase
A2 (um11026). Indeed, the monoacylglycerol inhibitor URB602
[51,52] prevented the degradation of the lipid bodies and
neutralized the antifungal effect of terbinafine-loaded TFVs. The
most likely explanation for these results is that fungal lipases attack
the incoming TFVs by metabolizing their lipids. This activity
releases the enclosed terbinafine and also leads to the aggregation
of the remaining membrane fragments into lipid bodies (Fig. 8).
This process might also be dependent on the concentration of
Tween 80, as the surfactant is a substrate for lipases and esterases
[76].
Conclusions
Terbinafine in TFVs (TDT 067) has largely enhanced
antifungal activity on dermatophytes compared with conventional
terbinafine [18,20]. The data presented here on terbinafine-
induced disruption of the endoplasmic reticulum integrity confirm
these results, and they show that this applies to fungi in general.
We also report that the surfactant Tween 80 is key for uptake of
TFVs into the fungal cell. This might be due to its ability to soften
the membrane of the vesicles, which allows ultra-deformability and
passage through the small pores of the fungal cell wall. In addition,
Tween 80 might help to reduce unspecific binding of TFVs to the
fungal cell wall. Once inside the cell, the TFVs are attacked by
cytosolic fungal lipases that may use the Tween 80 and
phosphatidylcholine components of the TransfersomeH as sub-
strates (Fig. 8). This metabolic activity releases the enclosed
antifungal from the TFVs. Thus, the specific properties of these
vesicle carriers do (a) deliver water-insoluble cargo (such as the
fungicide terbinafine), (b) allow passage through the fungal cell
wall and (c) release their drug content due to the activity of
cytosolic fungal lipases. In other words, TFVs act as ‘‘Trojan
Horses’’ that efficiently deliver their cytotoxic cargo into the fungal
cell. It is important to note that this mode of action does neither
depend on the fungal pathogen, nor on the enclosed drug cargo.
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powerful ways to address infectious diseases caused by fungi.
Methods
Strains and plasmids
The effects of terbinafine and terbinafine-loaded TFVs on the
organization of fungal cells were investigated in strains of U. maydis
expressing organelle-specific GFP markers. The genotypes of all U.
maydis strains used in this study are listed in Table 1.
Strain AB33GRab5a expresses a fusion protein of GFP and the
endosome-specific small GTPase Rab5a [32]. In strain
AB33ERG, the endoplasmic reticulum is labeled by GFP fused
to a targeting sequence and a C-terminal retention signal [24].
Strain AB33GSKL expresses a fusion protein of GFP and
peroxisome-targeting signal (SKL [42]). Strain AB33LgaG
expresses the mitochondrial protein Lga1 [77]. In strain
AB33CPYG, vacuoles are labeled by fluorescent carboxy-pepti-
dase Y [42]. In strain AB33nG, the nuclei contain a fusion protein
of GFP and a nuclear localization signal [78].
The effect of the ionophore CCCP on endogenous ATP levels
was investigated using strain AB33G3Dyn2, in which the dynein
heavy chain is labeled by a triple-GFP tag [79], allowing the ATP-
dependent observation of the motility of single dynein motors [46].
The plasmid poCpYR [42] was digested with NcoI and HpaIt o
remove the triple mRFP tag which was replaced by a single GFP,
cut out of the cloning vector P123 using NcoI and HpaI resulting in
plasmid poCpYG. For transformation, the plasmid was digested
with McsI and HpaI and transformed ectopically in strain AB33.
Growth conditions
U. maydis liquid cultures were grown overnight in complete
medium containing 1% (w/v) glucose, shaking at 200 revolutions
per minute at 28uC. The yeast-like cells were harvested by
centrifugation at 3000 rpm in a desktop centrifuge and shifted to
filamentous growth by transferring them into nitrate-containing
minimal medium, as described previously [80]. All assays were
conducted at 10–14 h after induction of filamentous growth. Cell
wall-less protoplasts were prepared by removing the cell wall of
TransfersomeH-treated cells, as previously described [81].
Microscopy
Cells were observed using an IX81 motorized inverted
microscope (Olympus, Hamburg, Germany), equipped with a
VS-LMS4 Laser-Merge-System with solid state lasers (488 nm/
70 mW, Visitron System, Munich, Germany) and a PlanApo
1006/1.45 Oil TIRF objective (Olympus, Hamburg, Germany).
TransfersomeH-associated fluorescence was observed using the
HBO illumination of the IX81 microscope and standard DAPI
filter sets (377650/406/447660). Images were acquired using a
Photometrics CoolSNAP HQ2 camera (Roper Scientific, Ger-
many). All parts of the system were under the control of the
Figure 8. Working model of the mode of action of terbinafine-loaded TFVs in fungal cells. (A) Terbinafine-loaded TFVs contain Tween 80
(purple structures) at high concentration. Tween 80 reduces unspecific interaction with the cell wall and allows extreme deformation of the vesicle
membrane, thereby allowing entry of intact TFVs. Once inside the cytoplasm, ATP-dependent cytosolic lipases attack the TFVs and might metabolize
Tween 80. This results in collapse of the TransfersomeH membranes and the formation of lipid droplets. The digestion of the TransfersomeH
membranes releases terbinafine in the fungal cell. (B) In the presence of a lipase inhibitor, lipases cannot release the antifungal. Consequently,
terbinafine-loaded TFVs are no longer cytotoxic. (C) At lower levels of Tween 80 (phosphatidylcholine to Tween 80 ratio of 20:1 shown here),
terbinafine-loaded TFVs enter at much lower rates. Consequently, the vesicles are not degraded and are not cytotoxic.
doi:10.1371/journal.pone.0038181.g008
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Winnersh, UK). For lipid staining, cells that were treated with
standard fluorescent TFVs were incubated for 10 min in 1 mM
Nile Red (Sigma-Aldrich Ltd, Gillingham, UK; stock 10 mM in
methanol).
For transmission electron microscopy, hyphal growth of strain
AB33 was induced overnight, as described previously [80], and the
cells were incubated with fluorescent terbinafine-loaded TFVs (for
details see below). Cells were sedimented by centrifugation at
3000 rpm on a desktop centrifuge and pellets were fixed in
glutaraldehyde phosphate buffer (2.5% (v/v) glutaraldehyde in
0.1 M phosphate buffer, pH 7.4) overnight. After three washes in
1 M phosphate buffer (pH 7.4), cells were incubated for 1 h in 1%
osmium (w/v) in phosphate buffer, followed by three washes in
distilled water. The fixed pellets were incubated for 45 min in 2%
uranyl acetate (w/v in water) and after two washes in distilled
water cells were dehydrated by 15-min washes in 70%, 80%, 90%,
and 100% ethanol. After two additional washes in 100% ethanol,
pellets were incubated overnight in a 50:50 solution of 100%
ethanol: Spurr resin (w/v; Agar Scientific, Stansted, UK).
Subsequently, the pellets were transferred to 100% Spurr resin
overnight, and embedded by incubation at 60uC for 2 days. Ultra-
thin sections were cut and placed on nickel grids (Agar Scientific,
Stansted, Essex, UK), followed by staining with lead citrate [82].
Samples were investigated using a Jeol JEM 1400 transmission
electron microscope (JEOL, Ltd., Welwyn Garden City, UK).
For scanning electron microscopy, either TransfersomeH-
treated hyphal cells (15–25-min incubation) or 20–50 mlo f
concentrated TransfersomeH suspension was placed on 0.22 mi-
cron polycarbonate membrane and air dried for 2 min. Subse-
quently, the samples were attached to a cryo-sledge and rapidly
frozen in liquid nitrogen, followed by water sublimation at 295uC
for 3 min using the Alto 2100 chamber (Gatan Ltd., Oxfordshire,
UK). This was followed by gold sputtering and observation in Jeol
JSM-6390LV scanning electron microscope (JEOL, Ltd., Welwyn
Garden City, UK).
TransfersomeH uptake assays
TransfersomeH suspension with phosphatidylcholine to Tween
80 ratio (2:1; identical with the previously reported TDT 067 [20],
but labeled with fluorescent 1,6-diphenyl-1,3,5-hexatriene) and
TransfersomeH suspensions with various phosphatidylcholine to
Tween 80 ratios (5:1, 10:1, 20:1) were obtained from IDEA AG
(Munich, Germany). All TFVs were loaded with 15 mg/ml
terbinafine (AminoChemicals Ltd., Malta) and their membranes
were fluorescently labeled with 1,6-diphenyl-1,3,5-hexatriene [25]
(DPH; Molecular Probes, Invitrogen Corporation, Grand Island,
NY, USA) or DiO (Molecular Probes, Invitrogen Corporation,
Grand Island, NY, USA; DiO was used to acquire data for Movie
S2). For all uptake assays, 10% (v/v) of fluorescent terbinafine-
loaded TransfersomeH suspension was added to logarithmically
growing cells of U. maydis (see Table 1 for detailed strain
description). A volume of 1 ml of TransfersomeH-exposed cell
suspension was incubated on a turning wheel at room temperature
for 20–30 min (unless otherwise noted). Cells taken from these
assays were placed on 2% agar cushions and images were taken
using a HBO illumination devise of the IX81 Olympus microscope
at 1 s exposure time. To compare the effect of pure terbinafine
and terbinafine-loaded TFVs, was added at an effective concen-
tration of 20–100 mg/ml. In a parallel experiment, the respective
concentration of terbinafine enclosed in TFVs was applied which
resulted in a much reduced amount of TransfersomeH suspension
in these experiments (around 0.3% v/v). For request of
TransfersomeH suspensions used in this study for research
purposes contact Sam Yurdakul (Celtic Pharma Development
Services Europe Ltd., London, UK ; Email: sam.yurdakul@dev.
celticpharma.com).
Inhibitor treatments
To investigate the uptake of TFVs in the absence of F-actin,
fungal cells were pre-incubated in latrunculin A at 10 mM (stock:
20 mM in DMSO: Biomol, Exeter, UK) for 15–30 min.
Subsequently, 10% of standard fluorescent terbinafine-loaded
TransfersomeH solution was added and cells were incubated for an
additional 20–30 min. The cells were then placed onto a 2% agar
cushion containing the latrunculin A and directly observed under
the microscope. Images of blue fluorescence and green fluores-
cence were taken as described above. The respective volume of
DMSO was used in all control experiments. For experiments
shown in Figure 3C, LatA and DMSO treated cells were briefly
incubated with the endocytic marker dye FM4-64 (Molecular
Probes, Leiden, Netherlands), as previously described [33].
For ATP-depletion experiments, cells were pre-incubated for
15 min with 100 mM CCCP (carbonyl cyanide m-chlorophenyl-
hydrazone; Sigma-Aldrich Ltd, Gillingham, UK), treated with
10% standard fluorescent terbinafine-loaded TransfersomeH
suspension, and observed on agar cushions supplemented with
100 mM CCCP. For pulse-chase experiments, cells were treated
with standard fluorescent terbinafine-loaded TransfersomeH sus-
pension for 30 min, sedimented by centrifugation at 3000 rpm in
a desktop centrifuge, and re-suspended in TransfersomeH-free
medium. After a second centrifugation and resuspension in fresh
medium, a sample was immediately investigated at the microscope
and again after an additional 30 min turning at room temperature
in a 2 ml reaction tube. The respective volume of DMSO was
used in all control experiments.
To test for inhibition of lipases, 900 ml of cells were pre-
incubated for 30 min with the lipase inhibitors Orlistat (stock at
20 mM in DMSO; Sigma-Aldrich Ltd, Gillingham, UK) or
URB602 (stock at 20 mM in DMSO; Sigma-Aldrich Ltd,
Gillingham, UK), turning in a 2 ml reaction tube at room
temperature. Subsequently, 100 ml of fluorescent standard terbin-
afine-loaded TransfersomeH suspension was added (10% v/v; the
condition for a standard uptake assay). The respective volume of
DMSO was used in all control experiments.
Quantitative analysis of TransfersomeH-derived
fluorescence and image processing
The amount of TransfersomeH-associated fluorescence was
measured in 14-bit images that were taken as described above.
The average fluorescent intensity was measured in sections of
hyphal cells that extended 10–15 mm using the software
MetaMorph. Intensity scans were performed using the linescan
function of the software MetaMorph. Three-dimensional recon-
struction of fluorescent lipid bodies (Movie S2) was performed
using MetaMorph. Images were grey-scaled and processed using
MetaMorph. All statistical analyses were conducted using two-
tailed T-tests with the software Prism 4 (GraphPad, La Jolla, CA,
USA).
Supporting Information
Figure S1 Effect of terbinafine on the sub-cellular organization
in U. maydis hyphal cells. Note the fragmentation of mitochondria
and the collapse of endoplasmic reticulum in the presence of
terbinafine. All organelles were labeled by GFP-marker proteins
that are described in the Method section. Bar represents
micrometers.
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Figure S2 Cell wall-less protoplasts incubated with fluorescent
TFVs at 2:1 and 20:1 phosphatidylcholine to Tween 80 ratios.
TFV-derived fluorescent signals appear in the interior of the
rounded cells (A). Significantly less TFVs-derived signal is seen at
low Tween 80 to phosphatidylcholine ratios (B), suggesting that
Tween 80 fosters passage through the plasma membrane. Bar
represents micrometers.
(TIF)
Figure S3 Localization of fluorescent terbinafine-loaded TFVs
(red in both panels, TLT) and marker proteins for vacuoles
(carboxy-peptidase Y-GFP; left panel, CPY, green) and early
endosomes (GFP-Rab5a; right panel, green). Bar represents
micrometers.
(TIF)
Figure S4 Kymographs showing dynein motility in cells treated
with the solvent DMSO (control) and with 100 mg/ml of the
ionophore cyanide 3-chlorophenyl-hydrazone (CCCP). Motility
stopped due to the depletion of ATP. Diagonal lines indicate
motility, vertical lines indicate stationary signals. Bars represent
seconds and micrometers.
(TIF)
Movie S1 Organization and dynamics of the endoplasmic
reticulum in the presence of 30 mg/ml terbinafine in TFVs. Time
is given in seconds:milliseconds. The bar represents micrometers.
(MOV)
Movie S2 Three-dimensional reconstruction of fluorescent
bodies after 30-min treatment with DiO-labeled TFVs. The bar
represents micrometers.
(MOV)
Movie S3 Motility of the motor dynein in DMSO-treated cells
(control) and after 45 min in cells treated with the ionophore
cyanide 3-chlorophenyl-hydrazone (CCCP). No directed motility
of the motors is seen indicating that ATP levels are depleted. Time
is given in seconds:milliseconds. The bar represents micrometers.
(MOV)
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